Hair Loss Is a Potential Side Effect of Novel Oral Anticoagulants – Findings From the Dresden NOAC Registry (NCT01588119)
November 2012
in “
Blood
”
TLDR Hair loss can be a side effect of certain blood thinners.
The study from the Dresden NOAC Registry investigated hair loss as a potential side effect of novel oral anticoagulants (NOACs) like rivaroxaban and dabigatran. Among 938 patients, 12 reported new hair loss, resulting in an incidence rate of 4.4 per 100 patient years. All affected patients were female, but no correlation with demographic data, co-morbidity, or co-medication was found. The mean time to hair loss onset was 68±76 days after starting NOAC therapy. The study concluded that patients should be informed about this potential side effect, and further research is needed to identify risk factors.